For a study, researchers sought to examine the relationship between dietary salt admission and glaucoma by antihypertensive use in the Thessaloniki Eye Study (TES) populace. Members of TES at various rates and stages made up the review population. The frequency of relapses due to dietary salt intake was determined through self-reporting. The findings revealed a prevalence of open point glaucoma (OAG), also known as primary open angle glaucoma (POAG), as well as pseudoexfoliation (PEX). Strategic relapse was applied to investigate the connection between recurrent salt admission and glaucoma while simultaneously controlling for the influence of variables and separating the results according to the patients’ hypertension treatment. The review included 1,076 members 80.5 ± 4.4 years old, of whom 518 were female. There were 89/1,076 (8.3%) members with any OAG, 46/789 (5.8%) with POAG, and 287/1,030 (27.9%) with PEX. In members with antihypertensive use, successive verses never salt admission was related with expanded hazard of any OAG [adjusted chances proportion (aOR)=2.65, 95% CI=1.12, 6.28; n=784] and POAG (aOR=3.59, 95% CI=1.16, 11.11; n=578) in general, and furthermore in members with diastolic pulse <90 mm Hg (aOR=2.42, 95% CI=1.00, 5.84; n=735) for OAG. There was not a link that could be considered clinically significant between the amount of salt consumed and PEX, either in individuals with or without antihypertensive medication use. People who take antihypertensive medication might have a greater risk of developing OAG if they had next salty meals, according to findings from TES participants who were examined for OAG at the occurrence and commonness stages. In hypertensive patients, additional testing was essential to determine the cause of salt admission and glaucoma.
